度普利尤单抗治疗伴有鼻息肉的慢性鼻-鼻窦炎的不良反应。病例报告及叙述性综述 - Suppr

Adverse effects of dupilumab in chronic rhinosinusitis with nasal polyps. Case report and narrative review.

作者信息

Nitro Letizia, Bulfamante Antonio Mario, Rosso Cecilia, Saibene Alberto Maria, Arnone Flavio, Felisati Giovanni, Pipolo Carlotta

机构信息

Otolaryngology Unit, Santi Paolo e Carlo Hospital, Department of Health Sciences, Università degli Studi di Milano, Milan, Italy.

出版信息

Acta Otorhinolaryngol Ital. 2022 Jun;42(3):199-204. doi: 10.14639/0392-100X-N1911.

DOI:10.14639/0392-100X-N1911

PMID:35880360

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9330752/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7045/9330752/334c2eec311d/aoi-2022-03-199-g002.jpg

相似文献

Adverse effects of dupilumab in chronic rhinosinusitis with nasal polyps. Case report and narrative review.

Acta Otorhinolaryngol Ital. 2022 Jun;42(3):199-204. doi: 10.14639/0392-100X-N1911.

Efficacy of dupilumab on chronic rhinosinusitis with nasal polyps and concomitant asthma in biologic-naive and biologic-pretreated patients.

Ann Med. 2024 Dec;56(1):2411018. doi: 10.1080/07853890.2024.2411018. Epub 2024 Oct 4.

Efficacy and Safety of Dupilumab Versus Omalizumab in Chronic Rhinosinusitis With Nasal Polyps and Asthma: EVEREST Trial Design.

Am J Rhinol Allergy. 2022 Nov;36(6):788-795. doi: 10.1177/19458924221112211. Epub 2022 Jul 15.

Dupilumab for the treatment of chronic rhinosinusitis with nasal polyposis.

Expert Opin Biol Ther. 2021 May;21(5):575-585. doi: 10.1080/14712598.2021.1901881. Epub 2021 Apr 1.

Dupilumab in pediatric severe chronic rhinosinusitis with nasal polyps and asthma.

Eur Ann Otorhinolaryngol Head Neck Dis. 2024 Jan;141(1):55-56. doi: 10.1016/j.anorl.2023.06.006. Epub 2023 Aug 15.

Cost Utility Analysis of Dupilumab Versus Endoscopic Sinus Surgery for Chronic Rhinosinusitis With Nasal Polyps.

Laryngoscope. 2021 Jan;131(1):E26-E33. doi: 10.1002/lary.28648. Epub 2020 Apr 3.

Prevalence of type 2 inflammatory signatures and efficacy of dupilumab in patients with chronic rhinosinusitis with nasal polyps from two phase 3 clinical trials: SINUS-24 and SINUS-52.

Int Forum Allergy Rhinol. 2024 Mar;14(3):668-678. doi: 10.1002/alr.23249. Epub 2023 Aug 22.

Comorbid asthma in patients with chronic rhinosinusitis with nasal polyps: did dupilumab make a difference?

BMC Pulm Med. 2023 Jul 18;23(1):266. doi: 10.1186/s12890-023-02556-8.

Effectiveness of dupilumab versus endoscopic sinus surgery for the treatment of type-2 chronic rhinosinusitis with nasal polyps: a preliminary report.

Eur Arch Otorhinolaryngol. 2024 Mar;281(3):1317-1324. doi: 10.1007/s00405-023-08309-x. Epub 2023 Nov 1.

Real-World Adverse Events After Type 2 Biologic use in Chronic Rhinosinusitis with Nasal Polyps.

Laryngoscope. 2024 Jul;134(7):3054-3059. doi: 10.1002/lary.31305. Epub 2024 Feb 5.

引用本文的文献

Remission in chronic rhinosinusitis with nasal polyps treated with biologics: a real-life experience.

Eur Arch Otorhinolaryngol. 2025 Sep;282(9):4681-4690. doi: 10.1007/s00405-025-09619-y. Epub 2025 Aug 4.

Role of body mass index as a predictor of dupilumab efficacy in patients with severe chronic rhinosinusitis with nasal polyps.

Acta Otorhinolaryngol Ital. 2025 Feb;45(1):28-38. doi: 10.14639/0392-100X-N2841.

Comparison between clinical and cytological findings in chronic rhinosinusitis with nasal polyps treated with Dupilumab.

Eur Arch Otorhinolaryngol. 2024 Dec;281(12):6511-6521. doi: 10.1007/s00405-024-08958-6. Epub 2024 Sep 16.

Switching of biological therapy to dupilumab in comorbid patients with severe asthma and CRSwNP.

Eur Arch Otorhinolaryngol. 2024 Jun;281(6):3017-3023. doi: 10.1007/s00405-024-08461-y. Epub 2024 Feb 12.

Dupilumab's Impact on Blood Parameters in Nasal Polyposis: 18-Month Follow-Up in Real Life.

J Immunol Res. 2023 Sep 15;2023:4027701. doi: 10.1155/2023/4027701. eCollection 2023.

Effectiveness and Safety Profile of Dupilumab in Chronic Rhinosinusitis with Nasal Polyps: Real-Life Data in Tertiary Care.

Pharmaceuticals (Basel). 2023 Apr 21;16(4):630. doi: 10.3390/ph16040630.

本文引用的文献

Efficacy and safety of dupilumab in patients with uncontrolled severe chronic rhinosinusitis with nasal polyps and a clinical diagnosis of NSAID-ERD: Results from two randomized placebo-controlled phase 3 trials.

Allergy. 2022 Apr;77(4):1231-1244. doi: 10.1111/all.15067. Epub 2021 Oct 1.

Dupilumab reduces systemic corticosteroid use and sinonasal surgery rate in CRSwNP.

Rhinology. 2021 Jun 1;59(3):301-311. doi: 10.4193/Rhin20.415.

Burden of Disease in Chronic Rhinosinusitis with Nasal Polyps.

J Asthma Allergy. 2021 Feb 11;14:127-134. doi: 10.2147/JAA.S290424. eCollection 2021.

Real-world evidence of dupilumab efficacy and risk of adverse events: A systematic review and meta-analysis.

J Am Acad Dermatol. 2021 Jan;84(1):139-147. doi: 10.1016/j.jaad.2020.08.051. Epub 2020 Aug 18.

Prognostic value of the Sinonasal Outcome Test 22 (SNOT-22) in chronic rhinosinusitis.

Acta Otorhinolaryngol Ital. 2020 Apr;40(2):113-121. doi: 10.14639/0392-100X-N0364.

Therapeutic Potential of Dupilumab in the Treatment of Chronic Rhinosinusitis with Nasal Polyps: Evidence to Date.

Ther Clin Risk Manag. 2020 Jan 23;16:31-37. doi: 10.2147/TCRM.S210648. eCollection 2020.

Biologics for chronic rhinosinusitis with nasal polyps.

J Allergy Clin Immunol. 2020 Mar;145(3):725-739. doi: 10.1016/j.jaci.2020.01.020.

Biologics for chronic rhinosinusitis.

Cochrane Database Syst Rev. 2020 Feb 27;2(2):CD013513. doi: 10.1002/14651858.CD013513.pub2.

Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma.

Allergy. 2020 May;75(5):1023-1042. doi: 10.1111/all.14221. Epub 2020 Feb 24.

The role of biologics in chronic rhinosinusitis: a systematic review.

Int Forum Allergy Rhinol. 2020 Feb;10(2):165-174. doi: 10.1002/alr.22473. Epub 2019 Dec 23.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Adverse effects of dupilumab in chronic rhinosinusitis with nasal polyps. Case report and narrative review.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献